Lower serum IgA is associated with COPD exacerbation risk in SPIROMICS-Reference-Cited by-同舟云学术

Lower serum IgA is associated with COPD exacerbation risk in SPIROMICS

Published:2018-04-12 Issue:4 Volume:13 Page:e0194924
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Putcha Nirupama^ORCID,Paul Gabriel G.,Azar Antoine,Wise Robert A.,O’Neal Wanda K.,Dransfield Mark T.,Woodruff Prescott G.,Curtis Jeffrey L.,Comellas Alejandro P.,Drummond M. Bradley,Lambert Allison A.,Paulin Laura M.,Fawzy Ashraf,Kanner Richard E.,Paine Robert,Han MeiLan K.,Martinez Fernando J.,Bowler Russell P.,Barr R. Graham,Hansel Nadia N.,

Funder

National Heart, Lung, and Blood Institute

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference20 articles.

1. Serum IgA in Celiac Disease: The Unrecognized Importance of Partial IgA Deficiency;K Pallav;Gastroenterology

2. The clinical significance of immunoglobulin A deficiency;AH Latiff;Ann Clin Biochem,2007

3. Common variable immunodeficiency: clinical and immunological features of 248 patients;C Cunningham-Rundles;Clin Immunol,1999

4. Serum immunoglobulins and risk of infection: how low can you go?;DE Furst;Semin Arthritis Rheum,2009

5. Mucosal immunity in asthma and chronic obstructive pulmonary disease: a role for immunoglobulin A?;C Pilette;Proc Am Thorac Soc,2004

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The genetics and epidemiology of N- and O-immunoglobulin A glycomics;Genome Medicine;2024-08-09

2. Serum immunoglobulin levels in group E of chronic obstructive pulmonary disease: insights for clinical management and immunoglobulin therapy strategies;BMC Pulmonary Medicine;2024-08-02

3. Effect of hospitalization on equine local intestinal immunoglobulin A (IgA) concentration measured in feces;Journal of Equine Veterinary Science;2024-06

4. Chronic obstructive pulmonary disease (COPD) and COPD-like phenotypes;Frontiers in Medicine;2024-04-09

5. Serum Immunoglobulin Levels in Group E of Chronic obstructive pulmonary disease: Insights for Clinical Management and Immunoglobulin Therapy Strategies;2024-03-20